Spain· ES:64968
METVIX 160 mg/g CREMA
A medicinal product containing aminolevulinato de metilo, registered in Spain by Laboratorios Galderma S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- aminolevulinato de metilo
- Manufacturer
- Laboratorios Galderma S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo8037342EUR 208.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aminolevulinato de metilo in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLuxeraGalderma Nordic AB
- SwedenLuxera 160 mg/g KrämGalderma Nordic AB
- IrelandMetvix 160 mg/g creamGalderma International
- IcelandMetvixGalderma Nordic AB*
- NorwayMetvixGalderma Nordic AB
- GermanyLuxermGalderma Laboratorium Gmbh
- United StatesKRX Aesthetics PD-13 TherapyBY KIN AESTHETICS LLC
- United KingdomMetvix 16% creamGalderma (UK) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Luxerm, Metvix
- Belgium · Metvix
- Germany · Luxerm, Metvix
- Denmark · Metvix
- Finland · Metvix
- France · Metvixia
- United Kingdom (Northern Ireland) · Metvix
- Greece · Metvix
- Ireland · Metvix
- Iceland · Metvix
- Italy · Metvix
- Luxembourg · Metvix
- Malta · Metvix
- Netherlands · Metvix
- Norway · Metvix
- Portugal · Metvix
- Sweden · Luxera, Metvix
- Slovakia · Metvix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/11dc90ec-d375-4efb-80f8-d964725017fb GET /v1/drugs/11dc90ec-d375-4efb-80f8-d964725017fb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1028584800000}",
"nregistro": "64968",
"substance": "aminolevulinato de metilo"
}See everything about aminolevulinato de metilo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.